NCT05254132View on ClinicalTrials.gov

Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Non Small Cell Lung Cancer
Interventions
PROCEDURE

Liquid biopsy

Participants in the aRECIST group will undergo a blood draw for liquid biopsy analysis at baseline and follow up visits

Sponsors

Lead Sponsor

OncoRadiomics
All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

OncoRadiomics

INDUSTRY

NCT05254132 - Artificial Intelligence for Help Non-Small Cell Lung Cancer: Measure Cancer Biology and Treatment Response Via Imaging | Biotech Hunter | Biotech Hunter